Wiss. Publikationen // St. Vincenz-Krankenhaus Paderborn - Akademisches Lehrkrankenhaus der Georg-August-Universität Göttingen

Wissenschaftliche Publikationen durch Mitglieder der Klinik

Novel oral anticoagulants for stroke prevention in atrial fibrillation: Key trial findings and clinical implications. Goette A. Trends Cardiovasc Med. 2013 Jan 10. doi:pii: S1050-1738(12)00400-8. 10.1016/j.tcm.2012.10.001. [Epub ahead of print]

Enzymatic activity of DPIV and renin-angiotensin system (RAS) proteases in patients with left ventricular dysfunction and primary prevention implantable cardioverter/defibrillator (ICD). Lehmann HI, Wolke C, Malenke W, Röhl FW, Hammwöhner M, Bukowska A, Lendeckel U, Goette A. Int J Cardiol. 2012 Oct 10. doi:pii: S0167-5273(12)01189-8. 10.1016/j.ijcard.2012.09.083. [Epub ahead of print]

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P; ESC Committee for Practice Guidelines-CPG; Document Reviewers. Europace. 2012 Oct;14(10):1385-413. Epub 2012 Aug 24.

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P; ESC Committee for Practice Guidelines (CPG), Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S; Document Reviewers, Vardas P, Al-Attar N, Alfieri O, Angelini A, Blömstrom-Lundqvist C, Colonna P, De Sutter J, Ernst S, Goette A, Gorenek B, Hatala R, Heidbüchel H, Heldal M, Kristensen SD, Kolh P, Le Heuzey JY, Mavrakis H, Mont L, Filardi PP, Ponikowski P, Prendergast B, Rutten FH, Schotten U, Van Gelder IC, Verheugt FW. Eur Heart J. 2012 Nov;33(21):2719-47. doi: 10.1093/eurheartj/ehs253. Epub 2012 Aug 24.

Oxidative Stress and Microcirculatory Flow Abnormalities in the Ventricles during Atrial Fibrillation. Goette A, Bukowska A, Lillig CH, Lendeckel U.Front Physiol. 2012;3:236. doi: 10.3389/fphys.2012.00236. Epub 2012 Jul 5.

Nicotine, cigarette smoking and cardiac arrhythmia: an overview. D'Alessandro A, Boeckelmann I, Hammwhöner M, Goette A. Eur J Prev Cardiol. 2012 Jun;19(3):297-305. Review.

Therapy of atrial fibrillation in the critically ill. Willich T, Hammwöhner M, Goette A. Med Klin Intensivmed Notfmed. 2012 Jun;107(5):368-76. doi: 10.1007/s00063-012-0082-5. Epub 2012 Jun 13. German.

Atrial fibrillation and fibrosis: role of connective tissue growth factor. Lendeckel U, Wolke C, Goette A. Europace. 2012 Aug;14(8):1079-80. doi: 10.1093/europace/eus147. Epub 2012 May 22.

Atrial fibrillation: an inflammatory disease or a conformational disorder? Goette A. Can J Cardiol. 2012 Sep-Oct;28(5):529-30. doi: 10.1016/j.cjca.2012.03.016. Epub 2012 May 19.

Outpatient evaluation and management of patients with ventricular premature beats or non-sustained ventricular tachycardia. Svendsen JH, Goette A, Dobreanu D, Marinskis G, Mabo P, Blomström-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association. Europace. 2012 Feb;14(2):294-6. doi: 10.1093/europace/eus009.

Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial. Goette A, Schön N, Kirchhof P, Breithardt G, Fetsch T, Häusler KG, Klein HU, Steinbeck G, Wegscheider K, Meinertz T. Circ Arrhythm Electrophysiol. 2012 Feb;5(1):43-51. doi: 10.1161/CIRCEP.111.965178. Epub 2011 Dec 7.

Dronedarone prevents microcirculatory abnormalities in the left ventricle during atrial tachypacing in pigs. Bukowska A, Hammwöhner M, Sixdorf A, Schild L, Wiswedel I, Röhl FW, Wolke C, Lendeckel U, Aderkast C, Bochmann S, Chilukoti RK, Mostertz J, Bramlage P, Goette A. Br J Pharmacol. 2012 Jun;166(3):964-80. doi: 10.1111/j.1476-5381.2011.01784.x.

Neutral effects of statins to prevent atrial fibrillation recurrences after catheter ablation of atrial fibrillation: should we bury upstream therapy for secondary prevention of atrial fibrillation? Goette A.Heart Rhythm. 2012 Feb;9(2):179-80. doi: 10.1016/j.hrthm.2011.09.070. Epub 2011 Oct 12. No abstract available.

Induction of ventricular tachycardia during radiofrequency ablation via pulmonary vein ablation catheter in a patient with an implanted pacemaker. Hammwöhner M, Stachowitz J, Willich T, Goette A. Europace. 2012 Feb;14(2):298-9. doi: 10.1093/europace/eur260. Epub 2011 Aug 15.

Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. Kirchhof P, Lip GY, Van Gelder IC, Bax J, Hylek E, Kaab S, Schotten U, Wegscheider K, Boriani G, Brandes A, Ezekowitz M, Diener H, Haegeli L, Heidbuchel H, Lane D, Mont L, Willems S, Dorian P, Aunes-Jansson M, Blomstrom-Lundqvist C, Borentain M, Breitenstein S, Brueckmann M, Cater N, Clemens A, Dobrev D, Dubner S, Edvardsson NG, Friberg L, Goette A, Gulizia M, Hatala R, Horwood J, Szumowski L, Kappenberger L, Kautzner J, Leute A, Lobban T, Meyer R, Millerhagen J, Morgan J, Muenzel F, Nabauer M, Baertels C, Oeff M, Paar D, Polifka J, Ravens U, Rosin L, Stegink W, Steinbeck G, Vardas P, Vincent A, Walter M, Breithardt G, Camm AJ. Europace. 2012 Jan;14(1):8-27. doi: 10.1093/europace/eur241. Epub 2011 Jul 26. Review.

Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF)-Trial. Goette A, Schön N, Kirchhof P, Breithardt G, Fetsch T, Häusler KG, Klein HU, Steinbeck G, Wegscheider K, Meinertz T. Circ Arrhythm Electrophysiol. 2011 Dec 7. [Epub ahead of print]

Neutral effects of statins to prevent atrial fibrillation recurrences after catheter ablation of atrial fibrillation: Should we bury upstream therapy for secondary prevention of atrial fibrillation? Goette A. Heart Rhythm. 2011 Oct 12. [Epub ahead of print] No abstract available.

Asymmetric dimethylarginine predicts appropriate implantable cardioverter-defibrillator intervention in patients with left ventricular dysfunction. Lehmann HI, Goette A, Martens-Lobenhoffer J, Hammwöhner M, Röhl FW, Bukowska A, Ghanem A, Klein HU, Bode-Böger SM. Europace. 2011 Oct;13(10):1428-35. Epub 2011 Jul 13.

Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions. Kirchhof P, Nabauer M, Gerth A, Limbourg T, Lewalter T, Goette A, Wegscheider K, Treszl A, Meinertz T, Oeff M, Ravens U, Breithardt G, Steinbeck G; AFNET registry investigators. Thromb Haemost. 2011 Jun 6;105(6):1010-23. Epub 2011 May 5.

The vanishing story of angiotensin II receptor blockers in the treatment of atrial fibrillation. Goette A. Europace. 2011 Apr;13(4):451-2. Epub 2011 Mar 7.

[Techniques for occlusion of the left atrial appendage: chances and risks]. Goette A. Nervenarzt. 2011 Feb;82(2):172, 174-6, 178-9.

Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Schotten U, Verheule S, Kirchhof P, Goette A. Physiol Rev. 2011 Jan;91(1):265-325. Review. Erratum in: Physiol Rev. 2011 Oct;91(4):1533.

Update on Pharmacologic Approaches To Prevent Thromboembolism in Atrial Fibrillation: Are Thrombin and Factor Xa Inhibitors the Ultimate Answer? Wolfram O, Hammwoehner M, Gramley F, Goette A. Curr Vasc Pharmacol. 2010 Dec 14.

Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation. Aliot E, Capucci A, Crijns HJ, Goette A, Tamargo J. Europace. 2010 Dec 7.

[Heart rhythm disturbances and their treatment according to recent recommendations]. Hammwöhner M, Goette A. Dtsch Med Wochenschr. 2010 Dec;135(49):2461-76.

Physiologic and Pathophysiologic Role of Calpain: Implications for the Occurrence of Atrial Fibrillation. Bukowska A, Lendeckel U, Bode-Böger SM, Goette A. Cardiovasc Ther. 2010 Nov 25. doi: 10.1111/j.1755-5922.2010.00245.x.

The impact of rapid atrial pacing on ADMA and endothelial NOS. Goette A, Hammwöhner M, Bukowska A, Scalera F, Martens-Lobenhoffer J, Dobrev D, Ravens U, Weinert S, Medunjanin S, Lendeckel U, Bode-Böger SM. Int J Cardiol. 2010 Oct 4.

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH; ESC Committee for Practice Guidelines, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas PE, Widimsky P; Document Reviewers, Vardas PE, Agladze V, Aliot E, Balabanski T, Blomstrom-Lundqvist C, Capucci A, Crijns H, Dahlöf B, Folliguet T, Glikson M, Goethals M, Gulba DC, Ho SY, Klautz RJ, Kose S, McMurray J, Perrone Filardi P, Raatikainen P, Salvador MJ, Schalij MJ, Shpektor A, Sousa J, Stepinska J, Uuetoa H, Zamorano JL, Zupan I. Europace. 2010 Oct;12(10):1360-420. No abstract available.

[Registry and studies of the German Competence Network on Atrial Fibrillation (AFNET)] Nabauer M, Gerth A, Kirchhof P, Goette A, Limbourg T, Sprenger C, Hoffmann B, Willems S, Doll N, Schuchert A, Oeff M, Ravens U, Meinertz T, Steinbeck G, Breithardt G. Herzschrittmacherther Elektrophysiol. 2010 Sep;21(3):153-9. German.

Guidelines for the management of atrial Fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA); Endorsed by the European Association for the Cardio-Thoracic Surgery (EACTS); Authors/Task Force Members, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH. EUR Heart J 2010 Aug 29.

Registry and studies of the German Competence Network of Atrial Fibrillation (AFNET) Nabauer M, Gerth A, Kirchhof P, Goette A, Limbourg T, Sprenger C, Hoffmann B, Willems S, Doll N, Schuchert A, Oeff M, Ravens U, Meinertz T, Steinbeck G, Breithaupt G. Herzschrittmacherther Elektrophysiol. 2010 Aug 1. [Epub ahead of print] German

Rheumatoid pneumoconiosis (Caplan's syndrome). Schreiber J, Koschel D, Kekow J, Waldburg N, Goette A, Merget R. Eur J Intern Med. 2010 Jun;21(3):168-72. Epub 2010 Mar 2.PMID: 20493416 [PubMed - in process]

Aldosterone-receptor antagonism as a potential therapeutic option for atrial fibrillation. Lendeckel U, Dobrev D, Goette A. Br J Pharmacol. 2010 Apr;159(8):1581-3.PMID: 20388187 [PubMed - in process]

Clinical pharmacology and electrophysiological properties of dronedarone Lewalter T, Pittrow D, Goette A, Kirch W, Hohnloser S. Dtsch Med Wochenschr. 2010 Mar;135 Suppl 2:S43-7. Epub 2010 Mar 10

Clinical profile of the new antiarrhythmic drug dronedarone Schmitt J, Lewalter T, Pittrow D, Duray G, Goette A, Brachmann J, Hohnloser SH. Dtsch Med Wochenschr. 2010 Mar;135 Suppl 2:S38-42. Epub 2010 Mar 10.

Current antiarrhythmic drug therapy in atrial fibrillation. Goette A. Dtsch Med Wochenschr. 2010 Mar;135 Suppl 2:S33-7. Epub 2010 Mar 10.

Recent advances in the pharmacological treatment of cardiac arrythmias Gramley F, Himmrich E, Mollnau H, Theis C, Hammwohner M, Goette A. Drugs Today (Barc). 2009 Nov;45(11):807-24.

Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation. Girmatsion Z, Biliczki P, Bonauer A, Wimmer-Greinecker G, Scherer M, Moritz A, Bukowska A, Goette A, Nattel S, Hohnloser SH, Ehrlich JR. Heart Rhythm. 2009 Dec;6(12):1802-9. Epub 2009 Sep 3.

Stroke prevention versus bleeding risk of vitamin-K antagonists: a double-edged sword in patients with atrial fibrillation who require surgery. Dobrev D, Goette A, Ravens U. Cardiovasc Ther. 2009 Winter;27(4):223-5

Sudden cardiac death stratification in asymptomatic ventricular preexcitation. Cantú F, Goette A; EHRA Scientific Initiatives Committee. Europace. 2009 Nov;11(11):1536-7.

Calpain in Atrial Fibrillation: Friend or Foe? : Editorial to: "Anti-apoptotic effects of a calpain inhibitor on cardiomyocytes in a canine rapid atrial fibrillation model" by Yue Li et al. Lendeckel U, Goette A. Cardiovasc Drugs Ther. 2009 Oct 8. [Epub ahead of print] No abstract available.

Prospective, multicentre validation of a simple, patient-operated electrocardiographic system for the detection of arrhythmias and electrocardiographic changes. Kaleschke G, Hoffmann B, Drewitz I, Steinbeck G, Naebauer M, Goette A, Breithardt G, Kirchhof P. Europace. 2009 Oct;11(10):1362-8.

Cardiac-resynchronization therapy for the prevention of heart-failure events. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W. MADIT-CRT Trial Investigators.N Engl J Med. 2009 Oct 1;361(14):1329-38. Epub 2009 Sep 1.

Gender and age-dependent differences in the bradykinin-degradation within the pericardial fluid of patients with coronary artery disease. Bechtloff R, Goette A, Bukowska A, Kähne T, Peters B, Huth C, Wolke C, Lendeckel U. Int J Cardiol. 2009 Jul 8. [Epub ahead of print]

Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. Kirchhof P, Bax J, Blomstrom-Lundquist C, Calkins H, Camm AJ, Cappato R, Cosio F, Crijns H, Diener HC, Goette A, Israel CW, Kuck KH, Lip GY, Nattel S, Page RL, Ravens U, Schotten U, Steinbeck G, Vardas P, Waldo A, Wegscheider K, Willems S, Breithardt G. Eur Heart J. 2009 Dec;30(24):2969-77c. Epub .

Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'. Kirchhof P, Bax J, Blomstrom-Lundquist C, Calkins H, Camm AJ, Cappato R, Cosio F, Crijns H, Diener HC, Goette A, Israel CW, Kuck KH, Lip GY, Nattel S, Page RL, Ravens U, Schotten U, Steinbeck G, Vardas P, Waldo A, Wegscheider K, Willems S, Breithardt G. Europace. 2009 Jul;11(7):860-85. Epub 2009 Jun 16. No abstract available.

Nicotine, atrial fibrosis, and atrial fibrillation: do microRNAs help to clear the smoke? Goette A. Cardiovasc Res. 2009 Aug 1;83(3):421-2. Epub 2009 Jun 5. No abstract available.

The effects of G-CSF-induced mobilization of progenitor cells are limited by ADMA. Goette A, Wolfram O, Jentsch-Ullrich K, Martens-Lobenhoffer J, Scalera F, Lendeckel U, Bode-Böger SM. Int J Cardiol. 2009 Mar 19. [Epub ahead of print]

Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles. Goette A, Bukowska A, Dobrev D, Pfeiffenberger J, Morawietz H, Strugala D, Wiswedel I, Röhl FW, Wolke C, Bergmann S, Bramlage P, Ravens U, Lendeckel U. Eur Heart J. 2009 Jun;30(11):1411-20. Epub 2009 Mar 5.

Severe mitral regurgitation in a patient with a bluish right sclera: an 'extension' of Caplan's syndrome to the heart and eye. Goette A, Huth C, Behrens-Baumann W, Evert M. Eur J Intern Med. 2009 Jan;20(1):e1-2. Epub 2008 Mar 4. No abstract available.

Atrial expression of endothelial nitric oxide synthase in patients with and without atrial fibrillation. Bukowska A, Röcken C, Erxleben M, Röhl FW, Hammwöhner M, Huth C, Ebert MP, Lendeckel U, Goette A. Cardiovasc Pathol. 2009 Feb 10. [Epub ahead of print]

The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Nabauer M, Gerth A, Limbourg T, Schneider S, Oeff M, Kirchhof P, Goette A, Lewalter T, Ravens U, Meinertz T, Breithardt G, Steinbeck G. Europace. 2009 Apr;11(4):423-34. Epub 2009 Jan 18

The German Competence Network on Atrial Fibrillation (AFNET). Breithardt G, Dobrev D, Doll N, Goette A, Hoffmann B, Kirchhof P, Köster I, Kuck KH, Leute A, Meinertz T, Näbauer M, Oeff M, Ravens U, Schuchert A, Sprenger C, Steinbeck G, Willems S. Herz. 2008 Dec;33(8):548-55.

Performance and survival of transvenous defibrillation leads: need for a European data registry. Goette A, Cantu F, van Erven L, Geelen P, Halimi F, Merino JL, Morgan JM; Scientific Initiative Committee of the European Heart Rhythm Association. Europace. 2009 Jan;11(1):31-4. Epub 2008 Nov 11.

Wissenschaftliche Publikationen durch Mitglieder der Klinik

Webcam Neubau